What is Dogwood Therapeutics, Inc. (DWTX) stock price today?

Dogwood Therapeutics, Inc. (DWTX) currently trades at $1.43 per share. The stock has a market capitalization of $46.09M and a P/E ratio of —x.

Is DWTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Dogwood Therapeutics, Inc. has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -0.62.

Is Dogwood Therapeutics, Inc. financially healthy?

Dogwood Therapeutics, Inc.'s Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -0.62 places it in the distress.

DWTX

Dogwood Therapeutics, Inc.

NASDAQ: DWTX · HEALTHCARE · BIOTECHNOLOGY

$1.43

+5.93% today

Updated 2026-04-30

Market cap

$46.09M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-7.13

Dividend yield

—

52W range

$1 – $10

Volume

0.1M

Market cap

$46.09M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-7.13

Dividend yield

—

52W range

$1 – $10

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-0.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$14.00

+879.02%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -0.62 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-3.64M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-12.25M	$-5.30M	$-12.35M	$-34.26M	$-3.78M
EPS	—	—	—	—	$-7.13
Free cash flow	$-11.47M	$-4.87M	$-8.79M	$-15.62M	$-3.64M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DWTX	$46.09M	26	4.3	3.0	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Dogwood Therapeutics, Inc. trades at $1.43. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -0.62, it sits in the distress.

Frequently asked questions

What is Dogwood Therapeutics, Inc.'s stock price?

Dogwood Therapeutics, Inc. (DWTX) trades at $1.43.

Is Dogwood Therapeutics, Inc. overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Dogwood Therapeutics, Inc. (DWTX)?

The analyst target price is $14.00, representing +879.0% upside from the current price of $1.43.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-0.62 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

dwtx.com

Quick metrics

P/S ratio—

ROE-49.20%

Beta2.07

50D MA$2.45

200D MA$4.38

Shares out0.03B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

DWTX vs LLY →DWTX vs JNJ →DWTX vs ABBV →Stock screener →